Does nadir testosterone at the end of long term androgen deprivation therapy predict outcomes in high risk prostate cancer? Data from a phase III trial

Autor:	Sylvie Vass, Céline Lemaire, Abdenour Nabid, Marie Duclos, François Vincent, Redouane Bettahar, Boris Bahoric, A.-G. Martin, Robert Archambault, J.-P. Bahary, M.-P. Garant, Luis Souhami
Rok vydání:	2017
Předmět:	Androgen deprivation therapy Oncology medicine.medical_specialty Prostate cancer Endocrinology business.industry Urology Internal medicine medicine business medicine.disease Nadir (topography) Testosterone
Zdroj:	European Urology Supplements. 16:e96-e97
ISSN:	1569-9056
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ff85bdd23b011f761d208aaf4dc1b407 https://doi.org/10.1016/s1569-9056(17)30126-4 Zobrazit plný text záznamu Full Text from ScienceDirect